marijuana stocks

Blue Line Protection Group, Inc. (BLPG)

 
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue 475   269   237   51  
Cost of Revenue 291 262 221 5
Gross Profit 185   7   16   45  
Operating Expenses
Research Development
Selling General and Administrative 364 747 1,635 106
Non Recurring
Others 10 9 8 0
Total Operating Expenses
Operating Income or Loss (189) (749) (1,626) (61)
Income from Continuing Operations
Total Other Income/Expenses Net 207 2 1
Earnings Before Interest And Taxes 18 (747) (1,625) (61)
Interest Expense 11
Income Before Tax 7 (747) (1,625) (61)
Income Tax Expense
Minority Interest
Net Income From Continuing Ops 7 (747) (1,625) (61)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income 7   (747) (1,625) (61)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares 7   (747) (1,625) (61)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Aphria Inc. (APHA) Adult-Use Brands Good Supply and Solei Introduce High Potency Oils to its Product Lineup

Aphria Inc.’s Adult-Use Brands Good Supply and Solei Introduce High Potency Oils…

GTEC Holdings Ltd. (GTEC.V) (GGTTF) Announces Supply Agreement with Namaste Technologies & Cannmart

GTEC Announces Supply Agreement with Namaste Technologies & Cannmart GTEC Holdings Ltd.…

The Green Organic Dutchman Holdings Ltd. (TGOD) (TGOD.TO) Launches its Premier Certified Organic Cannabis Brand

The Green Organic Dutchman Launches its Premier Certified Organic Cannabis Brand The…

INSYS Therapeutics, Inc. (INSY) Initiates Phase 2 Clinical Trial of Cannabidiol (CBD)

INSYS Therapeutics Initiates Phase 2 Clinical Trial of Cannabidiol (CBD) for Treatment…